ODDB.org: Open Drug Database | Drugs

Bonjesta 20 mg / 20 mg, Tablette mit veränderter Wirkstofffreisetzung - 50

Swissmedic Key	68867005	Registration Holder	Exeltis Suisse SA
Name	Bonjesta 20 mg / 20 mg, Tablette mit veränderter Wirkstofffreisetzung	Date of registration	05.12.2023
		Introduction of Sequence	05.12.2023
ATC-Classification	Doxylamine, Combinations (R06AA59)	Revision date
WHO	WHO-DDD	Valid until	04.12.2028
Index Therapeuticus (BSV)	07.13.10.	Show package size	50
Index Therapeuticus (Swissmedic)	01.09.	Description
Swissmedic categorie.	B
SL Eintrag	No	Indication
Information for professionals	IP	Consumer information	CI
Ex-factory-Price	PR
Deductible	k.A.	Consumer price	PR
Feedback	FB
GTIN	7680688670059	Medication Code	Synthetika
Pharmacode		Disponibility

Composition

doxylamini hydrogenosuccinas 20 mg, pyridoxini hydrochloridum 20 mg, cellulosum microcristallinum, magnesii trisilicas, carmellosum natricum conexum, magnesii stearas, silica colloidalis anhydrica, Überzug: hypromellosum, triethylis citras, simeticoni emulsio cum dimeticonum et polysorbatum 65 et silica colloidalis et methylcellulosum et poly(dimethylsiloxani) elastomerum et mono/diglycerida et acidum sulfuricum et E 200 et E 210 0.007 µg, acidi methacrylici et ethylis acrylatis polymerisatum 1:1, talcum, silica colloidalis anhydrica, natrii hydrogenocarbonas, natrii laurilsulfas, poly(alcohol vinylicus), titanii dioxidum, macrogolum 3350, E 172 (rubrum), E 172 (nigrum), cera carnauba, Drucktinte: lacca, E 129, propylenglycolum, E 132, ammoniae solutio 28 per centum, simeticonum, pro compresso obducto corresp. natrium 0.38 mg.

Packungsbestandteile

Galenic Form

Tablette mit veränderter Wirkstofffreisetzung

Active Agent	Dose
Doxylamine Hydrogenosuccinate	20 mg
Pyridoxine Hydrochloride	20 mg

BAG: Active Agent	Dose
Doxylamine Hydrogenosuccinate	20 mg
Pyridoxine Hydrochloride	20 mg

Inactive agents	Dose	additional_information
(Nigrum)
(Rubrum)
Acidi Methacrylici
Sulfuric Acid
Ammoniae Solutio	28
Carmellosum Natricum Conexum
Cellulosum Microcristallinum
Cera Carnauba
E 129		color.
E 132		color.
E 172		color.
E 200		conserv.
E 210	0.007 µg	conserv.
Ethylis Acrylatis Polymerisatum
Hypromellosum		Überzug
Lacca		Drucktinte
Macrogol	3350
Magnesii Stearas
Magnesium Trisilicate
Mono/diglycerida
Sodium Hydrogen Carbonate
Natrii Laurilsulfas
Per Centum
Poly(Alcohol Vinylicus)
Pro Compresso Obducto
Propylenglycol
Silica Colloidalis Anhydrica
Simeticoni Emulsio cum Dimeticonum et Polysorbatum 65 et Silica Colloidalis et Methylcellulosum et Poly(Dimethylsiloxani) Elastomerum
Simeticone
Talcum
Titanium Dioxide
Triethylis Citras

Source

Data was imported : 05.01.2024 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :

2025	©ywesee GmbH